Please select the option that best describes you:

What are alternative myeloma therapies for patients who are unable to afford lenalidomide or oral cyclophosphamide due to gaps in prescription drug coverage?  

Several patients with inability to access oral cyclophosphamide or lenalidomide, have attempted assistance and grants to no avail.



Answer from: Medical Oncologist at Academic Institution